Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Pharmacosmos A/S
Pharmacosmos A/S
The Canadian College of Naturopathic Medicine
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
Guy's and St Thomas' NHS Foundation Trust
RenJi Hospital
G1 Therapeutics, Inc.
Hubei Cancer Hospital
Surgery Bitenc
Ciusss de L'Est de l'Île de Montréal
CSL Behring
M.D. Anderson Cancer Center
EMD Serono
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Genentech, Inc.
Merck KGaA, Darmstadt, Germany
Yonsei University
Merck KGaA, Darmstadt, Germany
Instituto Nacional de Cancer, Brazil